Systematic Review of Medications for Alcohol Use Disorder
-
Register
- Administrative Staff - Free!
- Counselor (CAADE, CADTP, CCAPP, LPC, LMHC NCC, etc.) - Free!
- PhD - Free!
- Nurse (MSN, LPN, RN, LVN) - Free!
- Nurse Practitioner (APRN, DNP) - Free!
- Pharmacist (PharmD) - Free!
- Physician (MD) - Free!
- Physician (DO) - Free!
- Physician (MBBS) - Free!
- Physician Associate (PA-C) - Free!
- Psychologist (PsyD) - Free!
- Social Worker (MSW, LCSW, LGSW) - Free!
- Student/Resident/Fellow - Free!
- Other - Free!
Systematic Review of Medications for Alcohol Use Disorder
Host: American Academy of Addiction Psychiatry
Recorded: January 30, 2025
Enduring Training
Overview
Unhealthy alcohol use is the third leading cause of preventable death in the United States. However, only 10% of individuals with alcohol use disorder (AUD) receive any treatment for AUD, and less than 2% of individuals with AUD receive medication treatment for alcohol use disorder (MAUD). This 60-minute webinar presented by Dr. Melissa Weimer provides an in-depth review of the evidence for FDA and non-FDA approved MAUD, including theoretical mechanisms of effectiveness and potential treatment algorithms. This course is not eligible for credit.
The target audience for this intermediate level activity includes: Prescribers of all types
Learning Objectives
Upon completion, learners will be able to:
- Identify gaps in medication treatment of alcohol use disorder (AUD).
- Describe the current evidence for the use of medications for alcohol use disorder (MAUD).
- Evaluate ways to integrate MAUD into your clinical practice.
Open Registration: 08/01/2024 - 08/01/2027
Close Access Date: 09/01/2027
Instructions
- Click on the Contents tab to begin this activity.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcss@asam.org.
Melissa B. Weimer
DO, MCR, FASAM
Yale School of Medicine
Melissa Weimer, DO, MCR, FASAM is board-certified in Internal Medicine and Addiction Medicine. She is an Associate Professor of Medicine and Public Health and Associate Program Director of the Addiction Medicine Fellowship at Yale University. She is an expert in hospital-based care for patients with substance use disorders and has worked with colleagues to develop successful hospital-based Addiction Medicine Consult Services at both Oregon Health & Science University and Yale University/Yale New Haven Hospital. Dr. Weimer is also a national leader in Addiction Medicine education and has developed curricula for substance use disorder evaluation and treatment and safe and effective pain treatment. Dr. Weimer serves on the national board of ASAM and is the Chair of the ASAM Clinical Practice Guidelines Methodology and Oversight Committee.
No disclosures.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This activity is not for credit.
Key:
Complete
Next
Failed
Available
Locked